DOH Logo
Immunization Program

CHILD Profile

Immunization Logo
skip main navigation

DTaP (Diphtheria, Tetanus, acellular Pertussis) Vaccine

DTaP is one of four vaccines used to prevent diphtheria, tetanus, and pertussis. DTaP is given to children younger than age 7 years.

Children under 7 who cannot tolerate the pertussis component in DTaP can get vaccinated with  DT because it does not contain pertussis and is used as a substitute for DTaP for children who cannot tolerate the pertussis vaccine. Children should get 5 doses of DTaP, one dose at each of the following ages:

  • 2 months.
  • 4 months.
  • 6 months.
  • 15-18 months.
  • 4-6 years.

Washington State is currently supplying:

  • Sanofi Pasteur DTaP vaccine, brand name, Daptacel. The vaccine has typical availability.
  • Sanofi Pasteur DT vaccine, brand name, DT. The vaccine has typical availability.
  • GlaxoSmithKline DTaP/HepB/IPV vaccine, brand name, Pediarix. The vaccine has typical availability.

Immunization Guidelines for the Use of State Supplied Vaccine (PDF, 84 KB) (09/15/08)
Vaccine Management - Recommendation for Storage and Handling of Vaccines

Vaccine Information Statements:

  • DTaP.
  • Multiple Vaccines.
  • There is no separate vaccine information statement for combination vaccines. For patients receiving Pediarix, please give the vaccine information statements for DTaP, Hepatitis B, and IPV.

Fact Sheets:

Related Information:

External Resources:

 

Last Update: 09/16/2008 02:37 PM